Pages that link to "Q36756854"
Jump to navigation
Jump to search
The following pages link to Complement in immune and inflammatory disorders: therapeutic interventions (Q36756854):
Displaying 50 items.
- Complement inhibitors to treat IgM-mediated autoimmune hemolysis (Q26777628) (← links)
- Complement mediators: key regulators of airway tissue remodeling in asthma (Q26796418) (← links)
- Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches (Q26797414) (← links)
- The complement system and adverse pregnancy outcomes (Q26863600) (← links)
- Control of the collective migration of enteric neural crest cells by the Complement anaphylatoxin C3a and N-cadherin (Q27302883) (← links)
- Anti-Immune Strategies of Pathogenic Fungi (Q28071716) (← links)
- Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targets (Q28077955) (← links)
- Neutrophil homeostasis and inflammation: novel paradigms from studying periodontitis (Q28080991) (← links)
- On the Functional Overlap between Complement and Anti-Microbial Peptides (Q28082379) (← links)
- Platelets in inflammation and atherogenesis (Q28085020) (← links)
- Complement Evasion Mediated by Enhancement of Captured Factor H: Implications for Protection of Self-Surfaces from Complement (Q28268485) (← links)
- Fit for the Eye: Aptamers in Ocular Disorders (Q28828283) (← links)
- Pericytes and immune cells contribute to complement activation in tubulointerstitial fibrosis (Q30275101) (← links)
- Forcefield_NCAA: ab initio charge parameters to aid in the discovery and design of therapeutic proteins and peptides with unnatural amino acids and their application to complement inhibitors of the compstatin family. (Q30363657) (← links)
- A humanized antibody that regulates the alternative pathway convertase: potential for therapy of renal disease associated with nephritic factors (Q30409539) (← links)
- Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis (Q30582298) (← links)
- TMA: beware of complements (Q33410467) (← links)
- Molecules Great and Small: The Complement System (Q33419651) (← links)
- Complement in disease: a defence system turning offensive (Q33432423) (← links)
- A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples. (Q33568131) (← links)
- Electrostatic Steering Accelerates C3d:CR2 Association (Q33863349) (← links)
- New milestones ahead in complement-targeted therapy (Q33602320) (← links)
- Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles. (Q33925578) (← links)
- Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health (Q34003267) (← links)
- Conjugation to albumin-binding molecule tags as a strategy to improve both efficacy and pharmacokinetic properties of the complement inhibitor compstatin (Q34254555) (← links)
- Differential effects of complement activation products c3a and c5a on cardiovascular function in hypertensive pregnant rats (Q34360684) (← links)
- Complement System Part I - Molecular Mechanisms of Activation and Regulation (Q34481071) (← links)
- The extracellular adherence protein from Staphylococcus aureus inhibits the classical and lectin pathways of complement by blocking formation of the C3 proconvertase (Q34647356) (← links)
- Role of complement in host-microbe homeostasis of the periodontium (Q34727808) (← links)
- New compstatin peptides containing N-terminal extensions and non-natural amino acids exhibit potent complement inhibition and improved solubility characteristics (Q35013460) (← links)
- Affinity purification of human factor H on polypeptides derived from streptococcal m protein: enrichment of the Y402 variant (Q35053992) (← links)
- Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice. (Q35150544) (← links)
- Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters (Q35164180) (← links)
- Rare loss-of-function mutation in complement component C3 provides insight into molecular and pathophysiological determinants of complement activity (Q35205450) (← links)
- Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention (Q35236103) (← links)
- Complement in paroxysmal nocturnal hemoglobinuria: exploiting our current knowledge to improve the treatment landscape (Q35252156) (← links)
- Complement inhibition in a xenogeneic model of interactions between human whole blood and porcine endothelium (Q35252177) (← links)
- Complement involvement in kidney diseases: From physiopathology to therapeutical targeting (Q35567841) (← links)
- Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins (Q35655909) (← links)
- Peptide Inhibitor of Complement C1 (PIC1) Rapidly Inhibits Complement Activation after Intravascular Injection in Rats (Q35701952) (← links)
- Netrin-1 Reduces Monocyte and Macrophage Chemotaxis towards the Complement Component C5a. (Q36100438) (← links)
- Identification of C3b-Binding Small-Molecule Complement Inhibitors Using Cheminformatics. (Q36309711) (← links)
- Therapeutic control of complement activation at the level of the central component C3. (Q36363005) (← links)
- Adeno-associated virus mediated delivery of an engineered protein that combines the complement inhibitory properties of CD46, CD55 and CD59 (Q36380744) (← links)
- Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention (Q36460034) (← links)
- Uncoupling complement C1s activation from C1q binding in apoptotic cell phagocytosis and immunosuppressive capacity (Q36578796) (← links)
- The relative merits of therapies being developed to tackle inappropriate ('self'-directed) complement activation (Q36643354) (← links)
- Using an in vitro xenoantibody-mediated complement-dependent cytotoxicity model to evaluate the complement inhibitory activity of the peptidic C3 inhibitor Cp40. (Q36668896) (← links)
- Inhibition of pre-existing natural periodontitis in non-human primates by a locally administered peptide inhibitor of complement C3 (Q36717275) (← links)
- Complement in immune and inflammatory disorders: pathophysiological mechanisms (Q36756850) (← links)